Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention Among Women Living With HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation Trial

NCT06800664 is registered in ClinicalTrials.gov with Baylor University as lead sponsor.

NCT NCT06800664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06800664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention Among Women Living With HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation Trial
Lead sponsor
Baylor University
Phase
Not applicable
Overall status
Recruiting
Start date
November 11, 2025
Completion date
May 31, 2029
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer screening, hiv, implementation science, implementation strategies, intervention (training) condition, self-sampling